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Deﬁcient perception and cognition in Alzheimers disease (AD) has been attributed to slow information processing and atten-
tional disturbance, but an additional explanation may be reduced signal strength. In 21 individuals with probable AD, 29 healthy
older and 54 younger adults, we enhanced the contrast level of rapidly-ﬂashed masked letters. The AD group reached identiﬁcation
criterion (80% accuracy), but required signiﬁcantly higher contrast than the control groups. A source of the prevalent masking def-
icit may be reduced signal strength arising from dysfunction of retina or visual cortex. Increasing stimulus contrast may be an eﬀec-
tive means of enhancing cognitive performance in AD.
 2004 Elsevier Ltd. All rights reserved.
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Alzheimers disease (AD) is a neurological disorder
characterized by signiﬁcant abnormalities in visual per-
ception and cognition, some of which may arise from
lower-level visual deﬁcits (reviewed in Cronin-Golomb
& Gilmore, 2003). AD patients demonstrate impair-
ments in the spatial and temporal domains on multiple
low-level visual tasks (Cronin-Golomb et al., 1991, Cro-
nin-Golomb, Corkin, & Growdon, 1995; Rizzo, Ander-
son, Dawson, & Nawrot, 2000). It was found in a large
sample of AD patients (N = 72) that up to 50% of the
variance in performance on cognitive tests of object rec-
ognition could be accounted for by performance on one0042-6989/$ - see front matter  2004 Elsevier Ltd. All rights reserved.
doi:10.1016/j.visres.2004.10.017
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E-mail address: alicecg@bu.edu (A. Cronin-Golomb).test of basic vision, backward masking, with the next
best predictor, contrast sensitivity at low spatial fre-
quencies, accounting for up to 33% of the additional
variance in performance (Cronin-Golomb et al., 1995).
Pattern masking and low spatial frequency contrast sen-
sitivity were also the vision tests on which deﬁcits in AD
were the most prevalent, occurring in 59% and 33% of
patients, respectively (Mendola, Cronin-Golomb, Cor-
kin, & Growdon, 1995). Impaired contrast sensitivity
has been documented in AD using several methods (Gil-
more & Levy, 1991; Neargarder, Stone, Cronin-Go-
lomb, & Oross, 2003), suggesting that reduced
luminance sensitivity in patients and hence signal
strength on tests of perception and cognition may be a
common feature that in turn could account for dysfunc-
tion on a variety of tasks of basic vision and visual cog-
nition in this disorder. Here signal strength is conceived
as the proximal stimulus propagated in the visual system
of the observer. An observer with reduced contrast
1014 G.C. Gilmore et al. / Vision Research 45 (2005) 1013–1020sensitivity, such as an AD patient, will experience a
weaker proximal signal.
We focused the present study on delineating the rea-
sons for poor performance on a backward masking test
because of the sensitivity of this task to AD. The initial
studies described above varied the interval between the
presentation of the stimulus and the visual pattern
mask, thereby measuring possible slowing of informa-
tion processing rather than reductions in signal strength.
Reduced signal strength alone, however, would lead to
poor performance on this type of task. For example,
Hellige, Walsh, Lawrence, and Prasse (1979) demon-
strated that masking magnitude increased as the stimu-
lus energy in the target was reduced relative to the
mask energy. The ubiquity of the contrast sensitivity
deﬁcit recorded in AD has prompted us to consider
whether signal strength may be especially important to
understanding the masking deﬁcit.
This proposition follows from the ﬁndings of Gil-
more, Seone, Thomas, and Xue (1995), who hypothe-
sized that because light sensitivity declines with age
(McFarland, Domey, Warren, & Ward, 1960), impaired
performance by older adults on a masking task might
be the result of reduced luminance sensitivity rather
than slowed processing. On a backward masking task
using ﬁxed luminance for target and mask, increasing
age (young, middle-aged, and older adults) was associ-
ated (r[55] = .87) with an increase in the interstimulus
interval required to achieve a criterion level (75%) of
target identiﬁcation accuracy. When the interstimulus
interval was held constant but the target luminance
was increased until participants met a speciﬁed criterion
level of accuracy, the older adults yielded the same
masking magnitude as the young adults. This result sug-
gested that it is the age-related decrease in luminance
sensitivity and not slowed information processing that
leads to impaired performance on the masking test.
The interaction of sensory and cognitive or attentional
factors may be particularly important in understanding
masking eﬀects in aging populations (Atchley & Hoﬀ-
man, 2004), including those with the additional visual
and cognitive compromise conferred by neurodegenera-
tive disease.
Reduced signal strength may account for disrupted
masking performance by AD patients. Changes in con-
trast sensitivity may result in degradation of the initial
percept of the target and consequent impaired ability
to detect it. The visual signal, already degraded, would
be quite vulnerable to interference from the mask. Fur-
ther, the onset of AD occurs in later life when even
healthy adults experience an age-related decline in light
sensitivity (e.g., Eisner, Fleming, Klein, & Mauldin,
1987). We have forwarded a similar argument to ac-
count for poor masking performance in Parkinsons dis-
ease, another age-related neurodegenerative disorder
(Amick, Cronin-Golomb, & Gilmore, 2003).We hypothesized on the basis of the contrast sensitiv-
ity deﬁcit in AD that reduced signal strength is a pri-
mary factor in performance on tests of backward
masking. Moreover, we predicted that enhancing signal
strength would normalize AD performance on this type
of task across a range of dementia severity.2. Methods
This project was part of a large dual-site study of vi-
sion and cognition in AD. Recruitment and test proce-
dures and analytic methods were standard across the
two sites of the study, Boston University and Case Wes-
tern Reserve University.
2.1. Participants
The study compared the performance of 21 patients
with probable AD (10 men, 11 women), 29 healthy el-
derly control participants (EC) (10 men, 19 women),
and 54 healthy young adult control participants (YC)
(31 men, 23 women). Analyses (t-tests for homogeneous
variances) revealed that the AD and EC groups were
comparable in age (t[48] = 1.02, p = .31). Mean age
(standard deviation, SD) was 76.1 (6.1) years for AD;
74.4 (5.2) for EC, and 20.4 (3.4) for YC. All three
groups were matched for level of education
(F[2,100] = 1.8, p = .18). Mean education level was
15.2 (3.7) years for AD; 14.5 (3.0) for EC; 13.9 (1.6)
for YC.
AD patients were recruited through area hospitals
and day programs in Boston and Cleveland and all
met NINCDS-ADRDA criteria for probable AD
(McKhann et al., 1984). All participants were free of
confounding conditions such as depression or other
psychiatric disorders as well as ocular abnormalities
including glaucoma, cataracts, and macular degenera-
tion as determined from medical reports and detailed
neuro-ophthalmological examinations. Dementia sever-
ity in the AD group was measured by the Mini Men-
tal State Exam (MMSE) (Folstein, Folstein, &
McHugh, 1975). Total scores on the MMSE can range
from 0 to 30 with lower scores being indicative of
more severe dementia. The mean MMSE score (SD)
of our sample was 23.5 (3.1) with scores ranging from
17 to 29, indicative of mild to moderate dementia
severity.
EC were recruited from local communities or were
caregivers of AD patients. All were free of any signs
of dementia (MMSE mean 28.9, SD 1.1). YC were
undergraduates at Boston University or Case Western
Reserve University and participated as a voluntary
experience in one of their courses. All EC and YC par-
ticipants were free of ocular or other medical abnormal-
ities as determined by health history screening.
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tween the Boston and Cleveland samples, and data were
accordingly collapsed across sites for analysis.
2.2. Procedure
2.2.1. Acuity
Binocular central acuity was measured using the
Lighthouse Near Visual Acuity Test (2nd ed., New
York). The letter chart was given at a distance of
16 in., the same distance at which the masking test and
chart contrast sensitivity tests were administered. Partic-
ipants used their own refractive correction. All partici-
pants had acuity equal to or better than 20/50 (0.40
LogMAR).
The median acuity score for the AD group was 20/32
(0.20 LogMAR); for the EC group, 20/32 (0.20 Log-
MAR), and for the YC group, 20/16 (0.10 LogMAR).
Comparison of the frequency of acuities for the AD and
EC groups revealed no diﬀerences in the distribution of
acuities at the level of 20/25 or better vs 20/32 or worse
(v2 = .51, df = 1, p = .47).
2.2.2. Backward masking test of contrast sensitivity
We assessed contrast sensitivity with a backward
masking test. We have found such tasks to be very sen-
sitive to AD (Cronin-Golomb et al., 1995) and a more
sensitive measure of contrast sensitivity than are stan-
dard charts in widespread clinical use. We developed a
task that uses a ZEST procedure (Xue, Thomas, Gil-
more, & Wilson, 1998) to determine thresholds. ZEST
permits the reliable determination of a threshold in rel-
atively few trials, which is advantageous when testing
individuals with AD who may suﬀer from fatigue or
inattention earlier in a testing session than their healthy
counterparts.
In this test, participants identiﬁed brieﬂy presented
letters that were followed by a masking stimulus. Letter
stimuli appeared on the screen of a Mac G3 computer.
Participants were dark adapted for 10min and the task
was performed in a darkened room. The monitor was
viewed binocularly from a distance of 16 in. Each of
the four target letters H, O, T, and X was .475 in. in
height and subtended 1.7 of visual angle. Letters were
displayed within a box measuring 256 · 256 pixels, sub-
tending 10.6 by 10.6 of visual angle. This box func-
tioned as a background and was held at a constant
6.9cd/m2. Stimuli were presented on the screen for
12ms followed by a constant interstimulus interval of
59ms, followed by a visual mask for 506ms. The lumi-
nance of the mask was 25.7cd/m2. Stimulus timing was
synchronized to the monitors refresh signal. The visual
mask consisted of the target letters H, O, T, and X pre-
sented randomly in the mask such that the letters over-
lapped and ﬁlled the entire ﬁeld. The participant was
given the four-choice task to name out loud the letterﬂashed on the screen. A template with the four target
letters was displayed below the monitor to reduce de-
mands on memory for the letter set. The examiner re-
corded the verbal responses by keyboard.
The luminance of the target letters was varied using a
ZEST procedure to establish the luminance required to
achieve 80% target identiﬁcation accuracy. A 2.2 gamma
function was used to relate gray level to display lumi-
nance. The minimum luminance for this task was
6.9cd/m2 and the maximum luminance was 114.8cd/
m2. Contrast levels were calculated using the Michelson
contrast formula, (max Lum  min Lum)/(max Lum +
min Lum), where max Lum equaled the luminance of
the target and min Lum was the luminance of the con-
stant background.
The masking test was divided into ﬁve subtests. In the
practice subtest, participants were administered 20 trials
and the target letter was presented at the contrast of
85%. This subtest ensured that the participant under-
stood and could perform the task. For each of the sub-
sequent subtests, the only parameter that changed was
the contrast level of the target stimulus. The second
practice subtest served to orient the participant to the
process of threshold measurement. In this task, the tar-
get contrast required for the participant to achieve an
error rate of 20% (80% accuracy) was determined using
the ZEST staircase procedure. The stopping criterion in
the threshold estimation was a standard error of 20%.
The ﬁnal threshold estimate was determined on a third
subtest that used a stricter stopping criterion of 15%
standard error to once again determine the target con-
trast level required for participants to achieve an error
rate of 20%. The latter threshold estimate was used as
the estimate of the backward masking threshold. The
range in number of trials to obtain thresholds was about
46–48 for each group. Within the same subtest, there fol-
lowed an immediate presentation consisting of 20 trials
presented at the participants ﬁnal threshold level to
ensure that the threshold estimate was reliable. The
fourth subtest consisted of 20 trials presented at the
mean YC contrast threshold (14.96% Michelson) col-
lected from a pilot study, in order to estimate diﬀerences
in performance across groups on a comparable task.
Finally, all participants were presented with 10 trials
at the maximum contrast of 91% in order to ensure no
changes in baseline from the practice task.
2.2.3. Chart test of contrast sensitivity
The Functional Acuity Contrast Test (FACT) was
used to assess static contrast sensitivity (Ginsburg,
1996). Although not as sensitive as the masking test,
the chart test is used in clinical and research settings
and we employed it to demonstrate the comparability
of our sample to others reported in the literature.
The participants viewed the chart binocularly from a
distance of 16 in. The chart displayed a 9 by 5 array of
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sual angle. Standard procedures associated with this test
were followed. The lighting for the chart was within the
recommended luminance of 68–240cd/m2. Contrast de-
creased monotonically in nine steps from left to right
with a range of .602 to 2.255 (.59%–25% Michelson con-
trast), and a log step increment range of 0.109 to 0.176
(SD = .014).
Moving down a column, the gratings increased in
spatial frequency, including 1.5, 3, 6, 12, and 18 cycles
per degree. In each circle, the gratings were oriented
either vertically, tilted 15 to the left or 15 to the right.
The participants task was to indicate verbally or by
hand posture the direction in which the lines were ori-
ented. A contrast level was determined for each spatial
frequency by ﬁnding the minimal perceptible contrast
level needed to correctly identify the orientation of the
grating for a given row.3. Results
3.1. Masking
Diﬀerences among groups on the masking task were
analyzed using a one-way between-group analysis of
variance (ANOVA). Because preliminary analyses re-
vealed no gender diﬀerences in masking thresholds for
any of the three groups, we collapsed results across gen-
der for subsequent analyses. The groups diﬀered signiﬁ-
cantly for the contrast required to perform the masking
task at the 20% error rate (F[2, 101] = 132.3, p < .001)
(Fig. 1). AD participants required a mean contrast of
61% (SD 19) whereas the EC and YC groups required
a mean contrast of 46% (SD 16) and 14% (SD 5), respec-
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Fig. 1. Mean backward masking thresholds plotted as a function of
group. Error bars represent the standard error of the mean. The EC
group required signiﬁcantly higher contrast in order to reach the 80%
criterion level when compared to the YC group (a diﬀerence of 32%).
The AD group required even higher contrast when compared to the
EC group (a diﬀerence of 15% more).A priori comparisons using independent groups t-tests
revealed signiﬁcant diﬀerences between the YC and EC
groups (p < .001) and between the EC and AD groups
(p = .004).
To check the reliability of the threshold measure, the
participants were given 20 identiﬁcation trials at their
own threshold contrast level. There was no signiﬁcant dif-
ference among the number of errorsmade by theAD, EC,
and YC groups when each person was given stimuli at
their own contrast threshold (F[2, 100] = 2.4, p = .10).
The AD group had a mean of 75% correct (SD = 17),
the EC group had a mean of 83% correct (SD = 15),
and the YC group had a mean of 84% correct (SD = 16).
AD masking performance, in percent contrast re-
quired for letter identiﬁcation at criterion, correlated
with dementia severity as assessed by the MMSE
(r[19] = .67, p = .001) and with binocular near acuity
(Spearmans q[19] = .50, p = .02). EC masking perfor-
mance did not correlate with binocular near acuity
(q[27] = .11, p = .59). When we eliminated data from
individuals with acuity worse than 20/32 (9 AD, 3
EC), the percent contrast required to perform the task
at criterion remained the same for the EC (46%, SD
17) and was somewhat reduced from the full-group re-
sult for the AD (53%, SD 19). There was no correlation
between number of errors and AD dementia severity
(r[18] = .04, p = .88). There was no correlation be-
tween masking thresholds and age for AD (r[19] = .07,
p = 0.78) or YC (r[52] = .21, p = .12) whereas there was
a strong correlation for EC (r[27] = .39, p = .04).
Of the 21 AD patients, 16 were on cholinergic medi-
cations (donepezil, 14; rivastigmine, 1; galantamine, 1),
7 were on statins, and 5 were on non-steroidal anti-
inﬂammatories (NSAIDs). There were no signiﬁcant dif-
ferences in masking thresholds for medicated versus
non-medicated groups with respect to cholinergics
(t[19] = .15, p = .88), statins (t[19] = 1.66, p = .11), or
NSAIDs (t[19] = 1.98, p = .06).
3.2. Contrast sensitivity chart
A mixed design ANOVA with one between-subjects
variable (Group) and one within-subjects variable (Spa-
tial Frequency) was conducted to analyze YC, EC, and
ADs performance on the FACT assessment. Because a
violation of the sphericity assumption was noted, the
Huynh–Feldt correction was applied to the data
(e = .70). Results revealed a main eﬀect of group
(F[2,91] = 91.3, p < .001), a main eﬀect of spatial fre-
quency, which was expected because normal contrast
sensitivity varies according to spatial frequency
(F[2.8,253.7] = 447.1, p < .001), and a signiﬁcant inter-
action between group and spatial frequency
(F[5.6,253.7] = 37.6, p < .001) (Fig. 2). This signiﬁcant
interaction resulted from diﬀerences in performance be-
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Fig. 2. Mean log contrast sensitivity for the FACT assessment plotted
as a function of spatial frequency for the YC, EC, and AD groups.
Comparison of the EC and AD groups revealed a signiﬁcant diﬀerence
at 1.5 cycles per degree.
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the main eﬀect of group remained (F[1, 38] = 5.27,
p = .027). A priori contrasts performed via independent
groups t-tests using the Bonferroni correction (a = .05/
5 = .01) were conducted to examine diﬀerences between
the AD and EC groups at each level of spatial fre-
quency. A signiﬁcant diﬀerence between groups was
noted for the 1.5cpd (p < .001) FACT condition, with
AD having poorer contrast sensitivity than EC at this
spatial frequency.
There were signiﬁcant correlations of performance on
the masking test with performance on the FACT at sev-
eral spatial frequencies. Alpha was adjusted using the
Bonferroni correction (.05/5 = .01) to account for multi-
ple comparisons. For the YC group, masking thresholds
were correlated with the 12.0cpd FACT condition
(r[52] = .43, p = .001). For the EC group, a correlation
was noted for the 18.0cpd condition (r[24] = .48,
p = .01). For the AD group, correlations were noted
for the 3.0cpd (r[19] = .72, p = .00), 6.0cpd
(r[18] = .54, p = .01), and 12.0cpd (r[14] = .67,
p = .01) FACT conditions. It should be noted that the
correlations were likely aﬀected by the number of partic-
ipants performing at ceiling level on the FACT at the
several spatial frequencies, as we discuss elsewhere
(Morrison, Gilmore, & Cronin-Golomb, 2004). In gen-
eral, more YC performed at ceiling than did EC, and
more EC than did AD patients. The number performing
at ceiling for each spatial frequency was as follows. For
YC: 1.5cpd 41/54, 3.0cpd 43/54, 6.0cpd 37/54, 12.0cpd
16/54, and 18.0cpd 21/54. For EC: 1.5 18/24, 3.0 10/24,
6.0 3/24, 12.0 1/24, and 18.0 1/24. For AD: 1.5 6/16, 3.0
3/16, 6.0 2/16, 12.0 1/24, and 18.0 0/24.4. Discussion
The results of this study conﬁrm the hypothesis that
individuals with AD can perform normally on a back-ward masking task of letter identiﬁcation when the con-
trast level of the target stimulus is enhanced. The AD
group required signiﬁcantly higher contrast levels to per-
form the masking task at criterion level than did the
control groups. At these adjusted contrast levels, AD
patients performed at the same level of accuracy as both
control groups, indicating that neither slowed informa-
tion processing nor a general cognitive deﬁcit was para-
mount to understanding their poor initial performance.
Apparently the vision-related changes that accompany
AD can override the normal age-dependency of contrast
sensitivity changes as shown with our younger and older
control groups. Acuity was correlated with performance
on the masking test for the AD group, and we have
shown that even subtle group diﬀerences in acuity (AD
vs. healthy elderly) can aﬀect performance of tests of
contrast sensitivity (Neargarder et al., 2003).
The pattern of results from the EC relative to the
young adults was similar in kind to the pattern of results
from the AD patients relative to the EC, in that the ori-
ginal group diﬀerences on the masking test disappeared
when each person was given letters to identify at their
own contrast threshold. Under this condition, the EC
results (mean 83% correct, SD 15) were virtually indis-
tinguishable from the YC results (mean of 84% correct,
SD 16). This elimination of the aging eﬀect is consistent
with our ﬁndings with young and elderly adults (Gil-
more et al., 1995), in which we obtained the same mean
group thresholds when target luminance was increased
until individuals met a speciﬁed criterion level of accu-
racy. In that study, we demonstrated an aging eﬀect
when we varied the interstimulus interval between target
and mask but removed the eﬀect, when keeping the
interstimulus interval constant, by varying signal
strength. The earlier study provided direct evidence that
the age-related decrease in luminance sensitivity was
more important than slowed information processing in
explaining performance on the masking test. Although
we did not vary interstimulus interval in the present
study and so cannot make equivalent claims about the
relative importance of speed of processing and lumi-
nance sensitivity to masking performance, the results
of both studies are quite consistent in demonstrating
that enhancing signal strength alone is suﬃcient to elim-
inate the normal aging eﬀect on this type of task. More-
over, in the present study we have shown that
enhancement of signal strength eliminates not only the
age eﬀect, but also the dementia eﬀect.
Masking requires both retinal and cortical processing
(Atchley & Hoﬀman, 2004; Bowen & Wilson, 1994), and
deﬁcits in performance on masking tasks may result
from dysfunction at the retinal or cortical level in AD.
Parkinsons disease (PD), an age-related neurodegenera-
tive disorder arising from abnormalities in brain dopa-
mine levels, is also associated with reductions in
dopamine levels in the retina (Harnois & DiPaolo,
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1993). Neurochemical changes in the retina have been
used to explain the changes in contrast sensitivity often
noted in PD (Bodis-Wollner & Paulus, 1999), including
deﬁcient performance on the same masking test de-
scribed in the present AD study (Amick et al., 2003).
Alterations in dopamine levels have been linked to vi-
sual abnormalities in a range of disorders, including
amblyopia (Gottlob, Charlier, & Reinecke, 1992), co-
caine withdrawal (Desai, Roy, Roy, Brown, & Smelson,
1997), phenylketonuria (Diamond & Herzberg, 1996),
and schizophrenia (Calvert, Harris, & Phillipson, 1992;
Phillipson & Harris, 1985; Shuwairi, Cronin-Golomb,
McCarley, & ODonnell, 2002). AD likewise is associ-
ated with reduced dopamine (reviewed in Grossman,
1993; Joyce, 2001). It is noteworthy that dopamine
receptors are found in the occipital lobe (Parkinson,
1989; Phillipson, Kilpatrick, & Jones, 1987; Rakic &
Lidow, 1995) as well as the retina, in light of the signif-
icant neuropathology of visual association cortex and
anterior visual structures in this disorder (reviewed in
Cronin-Golomb & Gilmore, 2003; Valenti, 2004). Rela-
tively unexplored is the role of the known reductions of
acetylcholine in visual dysfunction in AD, though cho-
linergic neurons and postsynaptic receptors have been
found in the retina, lateral geniculate nucleus, and visual
cortices (Nobili & Sannita, 1997).
Dorsal stream dysfunction has been implicated in
deﬁcient performance on masking tasks (Husain, Shap-
iro, Martin, & Kennard, 1997; Saccuzzo, Cadenhead, &
Braﬀ, 1996). In AD, multiple aspects of dorsal stream
function are impaired, including motion and optic ﬂow
perception (Mapstone, Steﬀenella, & Duﬀy, 2003;
OBrien, Tetewsky, Cushman, Makous, & Duﬀy, 2001;
Tetewsky & Duﬀy, 1999), and several domains of visuo-
spatial function supported by the parietal lobes (re-
viewed in Cronin-Golomb, 2001; Cronin-Golomb &
Amick, 2001; Cronin-Golomb & Gilmore, 2003). In
the present study, we used letter-identiﬁcation masking,
thereby presumably assessing the function of the ventral
stream as well. Object and pattern discrimination deﬁ-
cits are common in AD, including diﬃculties in reading
letters and words (reviewed in Cronin-Golomb, 2001).
Besides impairments at lower levels of the visual system
in AD (reviewed in Valenti, 2004), there is direct disrup-
tion of the occipito-temporal pathway important for
word and object recognition (Arnold, Hyman, Flory,
Damasio, & Van Hoesen, 1991; Braak, Braak, & Kalus,
1989; Brun & Englund, 1981; Hof & Bouras, 1991;
Lewis, Campbell, Terry, & Morrison, 1987; Pearson,
Esiri, Hiorns, Wilcock, & Powell, 1985; Thompson
et al., 2003). There is a 20-fold increase in neuroﬁbrillary
tangle density, one of the pathological hallmarks of AD,
between primary and parastriate visual cortex (Brod-
mann area 18) and a further doubling in inferotemporal
cortex (area 20) (Lewis et al., 1987). Abnormalities ofboth the parvocellular and magnocellular input path-
ways to the cortical visual processing streams are evi-
dent in AD (Cronin-Golomb, 2001; Gilmore,
Morrison, & Groth, 2004; Kurylo et al., 1994).
In a previous study (Cronin-Golomb et al., 1995), it
was found that performance on a letter-identiﬁcation
masking task was the best basic-vision predictor of per-
formance on several object-associated tests in AD. In
this case, we varied the length of the interval between
target and mask, rather than varying signal strength.
Masking performance accounted for 25–50% of the var-
iance in performance on tests of incomplete-picture
identiﬁcation, word reading, picture arrangement, color
naming, complex ﬁgure copying, and pattern comple-
tion. It did not account signiﬁcantly for variance in per-
formance on tests of spatial localization, though there
were fewer such tests administered and therefore the do-
main was not as well sampled as the object recognition
domain. The ability of masking performance to predict
cognitive abilities in the domain of object recognition,
supported by the occipito-temporal pathway, is impor-
tant because of the prevalence of these cognitive deﬁcits
in AD, which may occur in an individual patient to a
greater degree than spatial localization deﬁcits sub-
served by the occipito-parietal pathway (Kurylo, Cor-
kin, Rizzo, & Growdon, 1996). Impairments in visual
cognition in turn predict functional disability in AD
(Glosser et al., 2002).
The results of the present study indicate that slowing of
information processing or other general cognitive impair-
ment does not necessarily account for deﬁcient perfor-
mance on tests of masking in AD, because when
proximal signal strength is enhanced, performance accu-
racy can be normalized. Although the relative roles of
luminance sensitivity and processing speed remain to be
speciﬁed, it is clear that signal strength makes an impor-
tant contribution to backward masking performance.
These ﬁndings suggest that interventions should be tar-
geted to enhancing the strength of the proximal signal.
Environmental modiﬁcations that are simple to imple-
ment include increasing the contrast of reading materials
and other aspects of the immediate visual world through
enhanced lighting, reduced glare, use of high-quality
print, and the adoption of large-typeface text in reading
materials (Dunne, 2004). Enhanced contrast has been
shown to normalize the speed of letter identiﬁcation in
AD (Gilmore, Thomas, Klitz, Persanyi, & Tomsak,
1996). In recent work, we demonstrated increased inges-
tion of food and liquid in severely demented AD patients
in long-term care through use of enhanced contrast of
dining tableware (Dunne, Neargarder, Cipolloni, & Cro-
nin-Golomb, 2004), and increased food intake together
with decreased agitation in the same type of patients using
high-contrast tableware and ampliﬁed lighting levels
(Koss & Gilmore, 1998). Our current ﬁnding that overall
mental status was correlated with level ofmasking perfor-
G.C. Gilmore et al. / Vision Research 45 (2005) 1013–1020 1019mance suggests that implementing interventions based on
signal strength may become more important as dementia
becomes more severe. It appears likely that a weakened
proximal signal may underlie a number of perceptual,
cognitive, and behavioral impairments in AD, and that
strengthening the visual signal may prove to be a new
and important non-pharmacological avenue for cognitive
and functional improvement in this disorder.Acknowledgements
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